Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: Gary Mohilner who wrote (2985)	4/5/2000 10:12:00 PM
From: RJMC	Read Replies (1) \| Respond to of 5665

I was at least hoping to see some information on the results when huC242-DM1 is used in combination with other treatments on the xenografts, especially with Taxane derivatives. Doesn't seem like it would take much to post this information on Immunogen's web page. The only data that I have seen published is how the drug does when standing alone, not when used in combination with other treatments. Oh well. I'm sure we'll hear something within the next few months.